NantHealth, Inc. entered into an unsecured subordinated promissory note agreement to receive $7,000,000 in funding on November 21, 2022. The transaction will include participation from returning lender Nant Capital, LLC. The note contains an 8.5% interest rate compounded annually and a maturity date of October 31, 2026.

The Nant Capital Note also contains semiannual interest payments due on April 15 and October 15 of each year. The payment of the note shall be subordinated and subject in right of payment to the prior payment in full of all senior debt.